0LDR Stock Chart & Stats
$8.98
-$0.17(-1.87%)
At close: 4:00 PM EDT
$8.98
-$0.17(-1.87%)
Day’s Range― - ―
52-Week Range$4.44 - $9.90
Previous CloseN/A
Volume2.48K
Average Volume (3M)21.42K
Market Cap
$1.22B
Enterprise Value$1.80K
Total Cash (Recent Filing)$774.35M
Total Debt (Recent Filing)$1.03B
Price to Earnings (P/E)―
Beta0.78
Next Earnings
Oct 28, 2026EPS Estimate
-0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.99
Shares Outstanding181,684,020
10 Day Avg. Volume23,670
30 Day Avg. Volume21,421
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)0.89
Price to Sales (P/S)0.49
P/FCF Ratio4.32
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$7.57Price Target Upside-15.69% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering18
EPS Forecast (FY)-0.87
Revenue Forecast (FY)$2.43B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash FlowConsistent positive operating and free cash flow provides durable financial flexibility to fund product investment, provider recruitment, and transition costs without heavy external financing. This cash generation reduces refinancing risk and supports multi-quarter operational initiatives.
Integrated Care Scale & Margin ExpansionA large covered-member base and expanding Integrated Care margins indicate structural economics in the core B2B subscription model. Stable membership plus mid-teens segment margins support durable profitability and predictable recurring revenue over the coming quarters.
Product And AI-driven Platform InnovationA unified care model and AI intelligence engine create a sustainable competitive edge by improving care coordination, outcomes measurement, and operational efficiency. These platform capabilities can deepen customer stickiness and lower unit care costs over time.
Bears Say
BetterHelp Revenue DeclineA pronounced decline in BetterHelp cash-pay revenue and a materially reduced segment outlook represent a structural headwind while the business shifts to insurance. Persistent revenue erosion in the mental-health consumer channel weakens consolidated top-line durability.
Provider Capacity Limits Insurance ConversionInsurance-driven growth depends on network capacity. Credentialing thousands of clinicians is necessary but insufficient; market-by-market provider supply constraints can chronically cap utilization and slow revenue recovery during the insurance transition.
Top-line Weakness And Continuing Net LossesDespite gross margin strength and cash flow, sustained negative net income and weak revenue trends limit operating leverage and investor returns. Continued top-line pressure makes it harder to convert margin gains into consistent GAAP profitability over the medium term.
Teladoc News
0LDR FAQ
What was Teladoc Inc.’s price range in the past 12 months?
Teladoc Inc. lowest share price was $4.43 and its highest was $9.90 in the past 12 months.
What is Teladoc Inc.’s market cap?
Teladoc Inc.’s market cap is $1.22B.
When is Teladoc Inc.’s upcoming earnings report date?
Teladoc Inc.’s upcoming earnings report date is Oct 28, 2026 which is in 82 days.
How were Teladoc Inc.’s earnings last quarter?
Teladoc Inc. released its earnings results on Jul 29, 2026. The company reported -$0.21 earnings per share for the quarter, beating the consensus estimate of -$0.25 by $0.04.
Is Teladoc Inc. overvalued?
According to Wall Street analysts Teladoc Inc.’s price is currently Overvalued.
Does Teladoc Inc. pay dividends?
Teladoc Inc. pays a Notavailable dividend of $0.285 which represents an annual dividend yield of N/A. See more information on Teladoc Inc. dividends here
What is Teladoc Inc.’s EPS estimate?
Teladoc Inc.’s EPS estimate is -0.21.
How many shares outstanding does Teladoc Inc. have?
Teladoc Inc. has 181,684,020 shares outstanding.
What happened to Teladoc Inc.’s price movement after its last earnings report?
Teladoc Inc. reported an EPS of -$0.21 in its last earnings report, beating expectations of -$0.25. Following the earnings report the stock price went down -29.443%.
Which hedge fund is a major shareholder of Teladoc Inc.?
Currently, no hedge funds are holding shares in GB:0LDR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Teladoc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.57 (-15.69% Downside)
$7.57 (-15.69% Downside)
Blogger Sentiment
Bullish
GB:0LDR Sentiment 64%
Sector Average ―
Sector Average ―
News Sentiment
Bearish
Bullish news 33%
Bearish news 67%
Bearish news 67%
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.95%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-4.68%
Trailing 12-Months
Company Description
Teladoc Inc.
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
0LDR Company Deck
0LDR Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mixed but balanced picture: clear strength and margin expansion in Integrated Care, meaningful product and AI-driven innovation (Teladoc 1 and Pulse), strong liquidity and disciplined cost actions. Offsetting these positives were material near-term challenges in BetterHelp as the business transitions from cash-pay to an insurance/in-network model — accelerated declines in cash-pay users, provider capacity constraints that limited insurance conversion, and a downward revision to consolidated revenue guidance. Management has taken decisive actions (national insurance rollout, provider recruitment/activation initiatives, lower ad spend) to address the issues, but execution risk and timing remain. Overall, the results show operational progress in core businesses and constructive steps to fix the BetterHelp transition, balanced by meaningful short-term revenue pressure and uncertainty in that segment.View all GB:0LDR earnings summaries0LDR Revenue Breakdown
56.44% Teladoc Health Integrated Care
43.56% BetterHelp
0LDR Stock 12 Month Forecast
Average Price Target
$7.57
▼(-15.69% Downside)
Technical Analysis
American Well
―
Doximity
―
VSee Health
―
Hinge Health, Inc. Class A
―
Omada Health, Inc.
―